Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | THRA | P10827 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29587376 | 0.85 | L3MBTL1 (0.50) | L3MBTL1MAPTNPSR1THRATHRB | |
| SCHEMBL47950 | 0.85 | L3MBTL1 (0.50) | L3MBTL1MAPTNPSR1THRATHRB | |
| SCHEMBL7064536 | 0.85 | L3MBTL1 (0.50) | L3MBTL1MAPTNPSR1THRATHRB | |
| SCHEMBL30850062 | 0.83 | PTGS2 (0.55) | L3MBTL1MAPTNPSR1TSHRHSD17B10 | |
| SCHEMBL47951 | 0.83 | L3MBTL1 (0.48) | L3MBTL1MAPTNPSR1THRATHRB | |
| SCHEMBL68677 | 0.83 | PTGS2 (0.55) | L3MBTL1MAPTNPSR1TSHRHSD17B10 | |
| SCHEMBL14244864 | 0.82 | L3MBTL1 (0.47) | L3MBTL1MAPTNPSR1THRATHRB | |
| SCHEMBL14244767 | 0.82 | L3MBTL1 (0.47) | L3MBTL1MAPTNPSR1THRATHRB | |
| SCHEMBL1835772 | 0.82 | L3MBTL1 (0.47) | L3MBTL1MAPTNPSR1THRATHRB | |
| SCHEMBL9554683 | 0.82 | L3MBTL1 (0.47) | L3MBTL1MAPTNPSR1THRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572911-B2 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJIFILM CORPORATION (JP) | 2009-08-11 | — | — | US | disclosed |
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJI PHOTO FILM CO., LTD. | 2007-07-26 | — | — | US | disclosed |
| US-7109336-B2 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJI PHOTO FILM CO., LTD. (JP) | 2006-09-19 | — | — | US | disclosed |
| US-20040122219-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJIFILM CORPORATION (JP) | 2004-06-24 | — | — | US | disclosed |
| EP-1377640-A2 | AZO COMPOUNDS AND PROCESS OF PRODUCING THE SAME AND NOVEL INTERMEDIATE COMPOUNDS USED IN THE PROCESS OF PRODUCING AZO COMPOUNDS | FUJI PHOTO FILM CO., LTD. (JP) | 2004-01-07 | — | — | EP | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |
| WO-2002083662-A2 | AZO COMPOUNDS AND PROCESS OF PRODUCING THE SAME AND NOVEL INTERMEDIATE COMPOUNDS USED IN THE PROCESS OF PRODUCING AZO COMPOUNDS | FUJI PHOTO FILM CO., LTD. (JP) | 2002-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | CYP4A11, CYP4F11, CYP4X1 | L3MBTL1 4878/4885MAPT 996/4885NPSR1 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.